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MORBIDITY THROUGH ACUTE STROKE IN ADULT POPULATION OF THE 
 REPUBLIC OF MOLDOVA AND REPUBLIC OF INDIA 
M A T E R I A L S  A N D  M E T H O D S  
 According to the WHO annually more than 15 million people worldwide suffers from stroke, 5.5 
million die and 5 million are left with permanent disability. Generally, ischemic strokes account 
for about 80% of stroke cases while hemorrhagic stroke accounts for 20% but the actual 
proportions of stroke types depend on the population. Approximately 1.1 million inhabitants of 
Europe suffered a stroke each year, because of the ageing population, the absolute number of 
stroke is expected to increase by 2025 to 1.5 million people . According to the latest WHO data 
published in 2017 Stroke Deaths in Republic of Moldova reached 6638 cases or 15.87% of total 
deaths. The age adjusted Death Rate is 121.53 per 100,000 of population and ranks Moldova 
39 in the world. Republic of India has been experiencing significant demographic and 
epidemiological transition during the past two decades. The cumulative incidence of stroke 
ranged from 105 to 152/100,000 persons per year, and the crude prevalence of stroke ranged 
from 44.29 to 559/100,000 persons in different parts of the country during the past decade. 
The high burden of stroke suggests that primary prevention strategies in the Republic of 
Moldova and Republic of India are either not widely implemented or not sufficiently effective; in 
addition to targeting behavioral risk factors, effective screening for conditions that increase 
stroke risk, such as hypertension, atrial fibrillation, and diabetes mellitus, is essential. 
R E S U L T S  
 
  In Republic of Moldova stroke is predominantly a problem of advancing age, the most 
affected categories of age are 61-70 years (23,0%), 71-80 years (33,0%) and patients 
over 80 years were 17,0%, patients over 70 years were 50,0%. In the ischemic stroke 
motor weakness was seen in 92.0%, speech involvement (38.0%), headache (33.0%), 
and altered sensorium (20%).  Analysis of the incidence of different risk factors in 
ischemic stroke were as follows: 42.6% hypertension, 32.7% smoking, 32.2% alcohol 
intake, 24.8% diabetes mellitus, 22.6% coronary artery disease, 18.6% dyslipidemia, 
16.6 % dysrhythmia, 13.4% previous stroke . In Republic of India age of onset of Stroke 
is highest in 40–49 years, which is the most  productive period of life. Analysis of the 
incidence of different risk factors in ischemic stroke were as follows: 66.3% patients 
were diabetic, 63.9% patients had atrial fibrillation,63.5% patients had ischemic heart 
angina ,61.3% patients were hypertensive and 59.1% had headache, history of stroke 
was presented  in 63.9% of cases, tabacco consumption in  36.4% and alcohol 
consumption in  66.0% cases. The most common reason among stroke patients who 
did not receive thrombolytic therapy in Republic of India were: hemorrhage on 
computed tomography (CT) scan ;exceedance of time window ;low or improved NIHSS 
score ; family refusal ;symptom onset is unknown, or if patient awoke with stroke; 
persistent elevated blood pressure ; and no alteplase availability. 
 A retrospective hospital-based study was conducted at the clinical base of the Department of 
Emergency Medicine, USMF "Nicolae Testemitanu" (IMSP Institute of Emergency Medicine) and 
a tertiary care Hospital of Assam, Assam Medical College, Republic of India. All medical records 
with a diagnosis of stroke were identified based on the ICD, R10, from January 01,2019 to 
December 31,2019. Two groups of patients was used for research, lot 1(80 patients) treated in 
IMSP Institute of Emergency Medicine (Chisinau, RM) and lot 2 (80 patients) treated in tertiary 
Hospital of Assam, Assam Medical College, Dibrugarh, India. The statistical processing of the 
results was performed using programs SPSS 22.0(SPSS inc). The study group I included 44 
(55.0%) males and 36 (45.0%) females. 66 patients (83.0%) had ischemic stroke and 14 
patients (17.0%) had hemorrhagic stroke. The mean age was 56.4 ± 14.38 years in ischemic 
stroke group and 53.24 ± 12.45 years in hemorrhagic stroke group. In ischemic stroke patients, 
35 (53.0%) were males and 31 (47.0%) were females. The study group II included 49 (61.6%) 
males and 31 (38.4%) females. 25 patients (31.0%) had ischemic stroke and 55 patients 
(69.0%) had hemorrhagic stroke. The mean age was 53.02 ± 14.38 years in ischemic stroke 
group and 52.84 ± 12.45 years in hemorrhagic stroke group. In ischemic stroke patients, 
15(60.0%) were males and 10 (40.0%) were females. Age distribution of patients in group I 
showed that 67.0 % of stroke patients were in the age group 61-80 years, 17.0 % patients were 
in the age group 20- 60 years, and 18.0% of patients were having age more than 80 years. Age 
distribution of patients with ischemic stroke in group II showed that about 55% of stroke 
patients were in the age group 30-60 years, 32.4% patients were of age 60-70 years, and 13% 
of patients were having age more than 70 years. 
 Analysis of stroke risk factors in population of the Republic of Moldova showed 
that the incidence of different risk factors in ischemic stroke were as follows: 
42.6% hypertension, 32.7% smoking, 32.2% alcohol intake, 24.8% diabetes 
mellitus, 22.6% coronary artery disease, 18.6% dyslipidemia, 16.6 % dysrhythmia, 
13.4% previous stroke, 10% inactivity, 8.8% transient ischemic stroke in the past. 
In our study, most common clinical presentation in group II of patients with 
ischemic stroke was history of TIA in 64.1% cases,disphagia  63.9%,speech 
problems 61.9%, ocular/visual simptoms 63.8%, weakness in fase/limbs 56% 
and change in consciousness in 50% of cases. Risk factor assessment among 
ischemic stroke patients found that history of stroke was presented in 63.9% of 
cases, tabacco consumption in 36.4%, alcohol consumption in 66.0% cases, 
66.3% patients were diabetic, 63.9% patients had atrial fibrillation,63.5% patients 
had ischemic heart angina and 61.3% patients were hypertensive. The most 
common reason among ischemic stroke patients who did not receive thrombolytic 
therapy in RM were: exceedance of time window 34.2%, low or improved NIHSS 
19.8%, uncontrolled blood pressure 6.8%, stroke mimics 5.6% and history of 
stroke in the past 3 months 4.2%, history of gastrointestinal bleeding 2.8%, 
uncertain onset 2.6%, family refusal1.4% and no alteplase availability 2.0. In the 
Republic of Moldova only 20,6% of ischemic stroke patients currently receive 
thrombolytic. The following most common reason among stroke patients  who did 
not receive thrombolytic therapy in Republic of India were: hemorrhage on 
computed tomography (CT) scan (42.3%),exceedance of time window  34.1%, low 
or improved NIHSS score 18.7%,family refusal 10.9%, symptom onset is unknown, 
or if patient awoke with stroke 17.2%,persistent elevated blood pressure 12.6%, 
intracranial neoplasm 2.7%,infective endocarditis 0.4%, GI malignancy or GI bleed 
within 21 days 3.7%, severe head trauma, or intracranial/intraspinal surgery 
within 3 months 2.7% and no alteplase availability 7.0%. In our study group II 
16.3% of acute ischemic stroke patients receive thrombolysis. 
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34,2 Exceedance of time window 34.2%; 
Low or improved NIHSS 19.8%;  
Uncontrolled blood pressure 6.8%; 
Stroke mimics 5.6%;  
History of stroke in the past 3 months 4.2%;  
History of gastrointestinal bleeding 2.8%; 
Uncertain onset 2.6%; 
Family refusal1.4% ,and 
No alteplase availability 2.0. 
F I G . 2  
To estimate the prevalence of risk factors for ischemic stroke and evaluation of barriers in 
ensuring access of patients to modern treatment strategies in the adult population of the 
Republic of Moldova and of the Republic of India. 
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Ischemic stroke  
No Yes Never used Formerly used Currently used
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In our study, 76.3% of acute stroke patients did not receive thrombolysis. 
Hemorrhage on computed tomography (CT) scan (42.3%).  
Exceedance of time window  24.1%.  
Low or improved NIHSS score 18.7%.  
Family refusal 10.9% .  
Symptom onset is unknown, or if patient awoke with stroke 17.2% 
Persistent elevated blood pressure 12.6% 
Intracranial neoplasm 2.7% 
Infective endocarditis 0.4% 
GI malignancy or GI bleed within 21 days 3.7% 
Severe head trauma, or intracranial/intraspinal surgery within 3 months 2.7% 
No alteplase availability 7.0% 
 
 
 
